Cargando…

PD41 - Risk factors for side effects during venom immunotherapy in children with hymenoptera venom allergy

Detalles Bibliográficos
Autores principales: Yavuz, Suleyman Tolga, Sahiner, Umit Murat, Buyuktiryaki, Betul, Arik Yilmaz, Ebru, Cavkaytar, Özlem, Sackesen, Cansin, Sekerel, Bulent E, Uysal Soyer, Ozge, Tuncer, Ayfer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4081903/
http://dx.doi.org/10.1186/2045-7022-4-S1-P41
_version_ 1782324175109619712
author Yavuz, Suleyman Tolga
Sahiner, Umit Murat
Buyuktiryaki, Betul
Arik Yilmaz, Ebru
Cavkaytar, Özlem
Sackesen, Cansin
Sekerel, Bulent E
Uysal Soyer, Ozge
Tuncer, Ayfer
author_facet Yavuz, Suleyman Tolga
Sahiner, Umit Murat
Buyuktiryaki, Betul
Arik Yilmaz, Ebru
Cavkaytar, Özlem
Sackesen, Cansin
Sekerel, Bulent E
Uysal Soyer, Ozge
Tuncer, Ayfer
author_sort Yavuz, Suleyman Tolga
collection PubMed
description
format Online
Article
Text
id pubmed-4081903
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40819032014-07-18 PD41 - Risk factors for side effects during venom immunotherapy in children with hymenoptera venom allergy Yavuz, Suleyman Tolga Sahiner, Umit Murat Buyuktiryaki, Betul Arik Yilmaz, Ebru Cavkaytar, Özlem Sackesen, Cansin Sekerel, Bulent E Uysal Soyer, Ozge Tuncer, Ayfer Clin Transl Allergy Poster Discussion Presentation BioMed Central 2014-02-28 /pmc/articles/PMC4081903/ http://dx.doi.org/10.1186/2045-7022-4-S1-P41 Text en Copyright © 2014 Yavuz et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Discussion Presentation
Yavuz, Suleyman Tolga
Sahiner, Umit Murat
Buyuktiryaki, Betul
Arik Yilmaz, Ebru
Cavkaytar, Özlem
Sackesen, Cansin
Sekerel, Bulent E
Uysal Soyer, Ozge
Tuncer, Ayfer
PD41 - Risk factors for side effects during venom immunotherapy in children with hymenoptera venom allergy
title PD41 - Risk factors for side effects during venom immunotherapy in children with hymenoptera venom allergy
title_full PD41 - Risk factors for side effects during venom immunotherapy in children with hymenoptera venom allergy
title_fullStr PD41 - Risk factors for side effects during venom immunotherapy in children with hymenoptera venom allergy
title_full_unstemmed PD41 - Risk factors for side effects during venom immunotherapy in children with hymenoptera venom allergy
title_short PD41 - Risk factors for side effects during venom immunotherapy in children with hymenoptera venom allergy
title_sort pd41 - risk factors for side effects during venom immunotherapy in children with hymenoptera venom allergy
topic Poster Discussion Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4081903/
http://dx.doi.org/10.1186/2045-7022-4-S1-P41
work_keys_str_mv AT yavuzsuleymantolga pd41riskfactorsforsideeffectsduringvenomimmunotherapyinchildrenwithhymenopteravenomallergy
AT sahinerumitmurat pd41riskfactorsforsideeffectsduringvenomimmunotherapyinchildrenwithhymenopteravenomallergy
AT buyuktiryakibetul pd41riskfactorsforsideeffectsduringvenomimmunotherapyinchildrenwithhymenopteravenomallergy
AT arikyilmazebru pd41riskfactorsforsideeffectsduringvenomimmunotherapyinchildrenwithhymenopteravenomallergy
AT cavkaytarozlem pd41riskfactorsforsideeffectsduringvenomimmunotherapyinchildrenwithhymenopteravenomallergy
AT sackesencansin pd41riskfactorsforsideeffectsduringvenomimmunotherapyinchildrenwithhymenopteravenomallergy
AT sekerelbulente pd41riskfactorsforsideeffectsduringvenomimmunotherapyinchildrenwithhymenopteravenomallergy
AT uysalsoyerozge pd41riskfactorsforsideeffectsduringvenomimmunotherapyinchildrenwithhymenopteravenomallergy
AT tuncerayfer pd41riskfactorsforsideeffectsduringvenomimmunotherapyinchildrenwithhymenopteravenomallergy